NEWS
SOFIE gets greenlight from US FDA to proceed to Phase II Pancreatic Cancer Study
Dulles, VA – November 10, 2021 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, has received [...]
SOFIE Submits Investigational New Drug Application to US FDA for Pancreatic Cancer Imaging
Dulles, VA - October 12, 2021 - SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, achieves [...]
SOFIE promotes Scott Boller to Chief Financial Officer
SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, has promoted the company’s long time Vice President [...]
Dr. Michael E. Phelps Awarded the Pioneer in Medicine Award from the Society of Brain Mapping & Therapeutics
The Society for Brain Mapping and Therapeutics (SBMT), the leading multi-specialty association for Brain Mapping, is holding its 17th/18th "Gathering for Cure" [...]
SOFIE to Commercially Supply FDA-Approved PYLARIFY® (piflufolastat F 18) Injection
SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, will be commercially manufacturing and distributing PYLARIFY® (piflufolastat [...]
Brian Schumer joins SOFIE as Chief Operating Officer
We are excited to welcome Brian Schumer to the SOFIE team. Brian joins SOFIE as a Chief Operating Officer. [...]